| Listed site | cdmo | cdmo |
|---|
| Summary | Global CDMO providing end-to-end contract development and manufacturing for pharma, biotech, and consumer health. Delivers 60+ billion doses annually across small molecules, biologics, cell & gene therapies, and clinical supply. | Sterile injectable CDMO specializing in fill-finish services for liquid and lyophilized vials, syringes, and cartridges, with Annex 1 compliant facilities and experience in biologics, small molecules, and vaccines. |
|---|
| Services | - Cell Therapy Manufacturing
- Viral Vector Manufacturing
- AAV Manufacturing
- Oral Solid Dosage Manufacturing
- Inhalation & Nasal Dosage Manufacturing
- Formulation Development
- Process Development
- CMC Analytical Development
- Technology Transfer
- Sterile Fill-Finish & Aseptic Manufacturing
- Quality Control Testing
- Recombinant Protein Manufacturing
- Biologics Development & Manufacturing
- API Synthesis & Manufacturing
- Small Molecule Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Secondary Packaging & Labeling
- Stability Testing & Storage
- CMC Regulatory Submission Support
- Allogeneic Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Vial Filling
- Prefilled Syringe (PFS) Filling
- Topical & Semi-Solid Manufacturing
- Serialization & Track-and-Trace
- Cold-Chain Storage & Logistics
- Cartridge Filling
- Lyophilization (Freeze Drying)
- Lentiviral Vector Manufacturing
| - Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Prefilled Syringe (PFS) Filling
- Cartridge Filling
- Lyophilization (Freeze Drying)
- Quality Control Testing
- Secondary Packaging & Labeling
- Serialization & Track-and-Trace
- Stability Testing & Storage
- CMC Analytical Development
- Technology Transfer
- CMC Regulatory Submission Support
- Controlled Substance Manufacturing
- Vaccine Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Biologics Development & Manufacturing
- API Synthesis & Manufacturing
- Small Molecule Development & Manufacturing
|
|---|
| Modalities | - Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy
- AAV / Viral Vector Platform
| - Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Vaccine
|
|---|
| Indications | Data not yet provided. | Data not yet provided. |
|---|
| Locations | - Headquarters, United States
- Asia Pacific, Asia Pacific
- Europe, Europe
- Latin America, Latin America
- North America, North America, United States
- China, China
- Japan, Japan
- North America, North America
- Headquarters / Global Operations
- Cell Therapy Center of Excellence, Princeton, New Jersey, United States
- Soft Chew Manufacturing, Manassas, Virginia, United States
- Global Network
| - Headquarters, Grand Rapids, Michigan, United States
- Headquarters
|
|---|
| Certifications | - GMP · Identifier: Nine GMP facilities
- FDA · Identifier: 21 CFR 111
- FDA · Identifier: 21 CFR 117
| - GMP · Identifier: Five GMP manufacturing facilities
- Annex 1 · Identifier: Three facilities designed and qualified with Annex 1 revisions
- GMP · Identifier: Five GMP manufacturing facilities; three Annex 1 compliant
- FDA · Identifier: GMP
- EMA · Identifier: Annex 1
- GMP · Identifier: Five GMP manufacturing facilities (three Annex 1 compliant)
|
|---|
| Reviews | Review summary appears after site-level review signal gate opens. | Review summary appears after site-level review signal gate opens. |
|---|